AC
LH icon

Abbrea Capital’s Labcorp LH Stock Holding History

Abbrea Capital’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$235K Sell
1,153
-414
-26% -$84.2K 0.03% 213
2024
Q1 		$342K Buy
+1,567
New +$345K 0.05% 198

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Abbrea Capital's LH Position: Q2 2024 in Review

Abbrea Capital reduced its Labcorp (LH) stake by 26% in Q2 2024, selling an estimated $84.2K and leaving 1,153 shares worth $235K. The position accounts for 0.03% of the portfolio, ranked #213.

Abbrea Capital first reported a position in LH in Q1 2024 and has held it in 2 quarters since. The position peaked at $342K in Q1 2024. 854 funds tracked by Wall St. Rank hold LH as of Q2 2024.

  • Abbrea Capital held 1,153 shares of Labcorp worth $235K as of Q2 2024.
  • Abbrea Capital sold 414 Labcorp shares in Q2 2024, an estimated $84.2K.
  • Labcorp made up 0.03% of Abbrea Capital's portfolio in Q2 2024, its #213 holding.
  • Abbrea Capital first reported a position in Labcorp in Q1 2024 and has held it in 2 quarters since.
  • Abbrea Capital's Labcorp position peaked at $342K in Q1 2024.
  • 854 funds tracked by Wall St. Rank held Labcorp as of Q2 2024.

Based on Abbrea Capital's 13F filing for Q2 2024, filed 8 Aug 2024.